Advertisement

Topics

DBV Tech Initiates Phase III Study Of Viaskin Peanut In Peanut-Allergic Patients One To Three Years Of Age

20:00 EDT 1 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: DBV Tech Initiates Phase III Study Of Viaskin Peanut In Peanut-Allergic Patients One To Three Years Of Age

NEXT ARTICLE

More From BioPortfolio on "DBV Tech Initiates Phase III Study Of Viaskin Peanut In Peanut-Allergic Patients One To Three Years Of Age"

Quick Search
Advertisement